Insufficient scRNA-seq data for expression of FBP2 at single-cell level.
Insufficient scRNA-seq data for expression of FBP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 95% | 135.85 | 312 / 328 | 25% | 0.68 | 44 / 178 |
stomach | 81% | 1473.11 | 291 / 359 | 34% | 1.29 | 97 / 286 |
muscle | 100% | 8694.27 | 803 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 80% | 52.79 | 207 / 258 | 3% | 0.12 | 7 / 230 |
bladder | 43% | 20.10 | 9 / 21 | 18% | 0.60 | 90 / 504 |
lung | 46% | 19.43 | 263 / 578 | 15% | 0.42 | 174 / 1155 |
esophagus | 4% | 2.95 | 55 / 1445 | 39% | 1.83 | 72 / 183 |
liver | 38% | 9.92 | 87 / 226 | 2% | 0.03 | 7 / 406 |
intestine | 16% | 7.92 | 154 / 966 | 20% | 0.55 | 106 / 527 |
prostate | 10% | 6.68 | 25 / 245 | 25% | 0.42 | 128 / 502 |
eye | 0% | 0 | 0 / 0 | 24% | 1.08 | 19 / 80 |
blood vessel | 22% | 9.80 | 299 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 3.21 | 6 / 29 |
skin | 7% | 5.21 | 120 / 1809 | 11% | 0.34 | 51 / 472 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.38 | 7 / 45 |
breast | 7% | 10.28 | 32 / 459 | 6% | 0.13 | 72 / 1118 |
kidney | 11% | 2.53 | 10 / 89 | 2% | 0.07 | 18 / 901 |
heart | 12% | 3.68 | 106 / 861 | 0% | 0 | 0 / 0 |
brain | 7% | 3.39 | 197 / 2642 | 2% | 0.05 | 12 / 705 |
uterus | 0% | 0 | 0 / 170 | 9% | 0.59 | 41 / 459 |
ovary | 1% | 0.31 | 2 / 180 | 7% | 0.10 | 28 / 430 |
adipose | 6% | 3.86 | 78 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 11.37 | 55 / 929 | 0% | 0 | 0 / 0 |
thymus | 3% | 14.96 | 18 / 653 | 2% | 0.04 | 12 / 605 |
spleen | 0% | 0.10 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005986 | Biological process | sucrose biosynthetic process |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_0006000 | Biological process | fructose metabolic process |
GO_0030388 | Biological process | fructose 1,6-bisphosphate metabolic process |
GO_0006094 | Biological process | gluconeogenesis |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0030018 | Cellular component | Z disc |
GO_0070161 | Cellular component | anchoring junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042132 | Molecular function | fructose 1,6-bisphosphate 1-phosphatase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | FBP2 |
Protein name | Fructose-1,6-bisphosphatase (EC 3.1.3.11) Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase) |
Synonyms | |
Description | FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations and probably participates in glycogen synthesis from carbohydrate precursors, such as lactate. . |
Accessions | Q9UJ73 O00757 Q9UMQ9 Q9UMR0 ENST00000375337.4 |